Mydecine Innovation's Mindleap subsidary launches a telehealth platform for psychedelics.
Kevin O’Leary won’t touch cannabis as an investment but he loves the potential of psychedelic drugs. Why?
Move over Big Pharma, Here Comes Silicon Valley Investment In Psychedelics Stocks Like Compass Pathways (CMPS)
Psychedelic stock warrants that are currently out of the money COULD produce big returns for investors.